PUBLISHER: The Business Research Company | PRODUCT CODE: 1855954
 
				PUBLISHER: The Business Research Company | PRODUCT CODE: 1855954
A point of care lipid test is a rapid diagnostic test that uses a fingerstick blood sample to measure cholesterol and triglyceride levels without sending samples to a central laboratory. It provides fast results to support cardiovascular risk assessment and ongoing monitoring.
The primary product types of point of care lipid tests are instruments, consumables, and others. Instruments include portable analyzers and testing devices designed to quickly assess lipid profiles, such as cholesterol and triglyceride levels, at or near the patient care site. These solutions are applied in conditions such as hyperlipidemia, hypertriglyceridemia, Tangier disease, hyperlipoproteinemia, familial hypercholesterolemia, and others. Key end users include hospitals, clinics, diagnostic laboratories, home care settings, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.
The point of care lipid test market research report is one of a series of new reports from The Business Research Company that provides point of care lipid test market statistics, including the point of care lipid test industry global market size, regional shares, competitors with the point of care lipid test market share, detailed point of care lipid test market segments, market trends, and opportunities, and any further data you may need to thrive in the point of care lipid test industry. This point of care lipid test market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The point of care lipid test market size has grown strongly in recent years. It will grow from $0.68 billion in 2024 to $0.74 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth during the historic period was driven by the rising prevalence of cardiovascular disease and dyslipidemia, expansion of multi-analyte and multiplex testing, increasing healthcare expenditure and reimbursement support, growing awareness and focus on preventive healthcare, and wider adoption in retail pharmacies, clinics, and community settings.
The point of care lipid test market size is expected to see strong growth in the next few years. It will grow to $1.07 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth during the forecast period is fueled by increasing adoption in home based and self-monitoring settings, rising awareness and screening for genetic lipid disorders, growing chronic disease burden, the shift toward value based healthcare models, and stable demand for consumables. The primary trends in the forecast period include advancements in portable technology, integration with digital health systems, incorporation into remote patient monitoring and telemedicine platforms, integration within IoMT or connected health infrastructure, and development of edge computing and low-power biosensor chips.
The growing prevalence of cardiovascular diseases is expected to drive the growth of the point-of-care lipid test market. Cardiovascular diseases encompass conditions affecting the heart and blood vessels, such as coronary artery disease, stroke, and hypertension, often resulting from atherosclerosis linked to abnormal cholesterol and triglyceride levels. The rise in cardiovascular diseases is largely due to sedentary lifestyles and decreased physical activity, leading to obesity, poor circulation, and other risk factors. Point-of-care lipid tests play a crucial role in managing this trend by offering rapid, on-site measurement of cholesterol and lipid levels, enabling early identification of risk and timely intervention to prevent further complications. For example, the American Heart Association reported in January 2024 that cardiovascular diseases caused 931,578 deaths, a rise of 3,000 compared to the previous year. This increasing burden of cardiovascular diseases is driving the demand for point-of-care lipid tests.
Leading companies in the point-of-care lipid test market are focusing on advanced diagnostic platforms to improve clinical decision-making and patient management. These platforms are portable, integrated devices capable of performing rapid, lab-quality lipid panel tests at the patient's bedside, allowing real-time decision-making and immediate treatment. For example, in July 2023, Vital Biosciences Inc., a health tech company based in Canada, introduced the VitalOne platform. This portable device delivers over 50 lab-grade blood test results in just 20 minutes at locations such as clinics and pharmacies. The platform combines hematology, clinical chemistry, and immunoassays in one device, enabling healthcare providers to perform testing, diagnosis, and treatment during a single visit. This innovation improves access, speed, and personalization of patient care, while maintaining accuracy comparable to traditional laboratory tests.
In May 2023, PTS Diagnostics, a US-based manufacturer of point-of-care testing devices, partnered with BIOSYNEX S.A. to enhance care for patients with chronic diseases worldwide. The collaboration aims to expand their point-of-care lipid and A1C testing services, improving cardiovascular and diabetes care on a global scale. BIOSYNEX, based in France, specializes in developing and distributing rapid diagnostic tests, including point-of-care lipid testing solutions.
Major players in the point of care lipid test market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthineers AG, Becton Dickinson and Company, Quidel Corporation, Bio-Rad Laboratories Inc., Horiba ABX SAS, Randox Laboratories Ltd., Sekisui Diagnostics LLC, Fisher Scientific International Inc., Everlywell Inc., EKF Diagnostics Holdings plc, Trinity Biotech plc, VivaChek Biotech (Hangzhou) Co. Ltd., EuroMedix International NV, A. Menarini Industrie Farmaceutiche Riunite S.r.l., AccuBioTech Co. Ltd., Callegari S.r.l., MiCo BioMed Co. Ltd., BHR Diagnostics Private Limited.
North America was the largest region in the point of care lipid test market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in point of care lipid test report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the point of care lipid test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The point of care lipid test market consists of revenues earned by entities by providing services such as lipid profile testing services, diagnostic support services, home-based testing services, and technical support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The point of care lipid test market includes the sale of test strips, lipid panel analyzers, handheld lipid testing devices, cholesterol testing devices, multi-parameter testing devices, lancets, control solutions, reagent kits, wireless lipid testing devices, and Bluetooth-enabled lipid monitors. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Point Of Care Lipid Test Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on point of care lipid test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for point of care lipid test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The point of care lipid test market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
 
                 
                 
                